2 active not recruiting, 1 completed, 1 unknown. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 2, Completed 1, Unknown 1 |
Follow Acoustic Neuroma: new trials by email Literature Review of Acoustic Neuroma trials Research Report on Acoustic Neuroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
| Study of Aspirin in Patients With Vestibular Schwannoma Aspirin, Placebo - Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Active not recruiting | Massachusetts Eye and Ear Infirmary | 97 | 2018-03-01 | 2026-10-16 |
| RGD PET/MRI in Sporadic Vestibular Schwannoma One injection of 68Ga-NODAGA-E[c(RGDyK)]2 - Acoustic Neuroma | Phase 2 | Unknown | Copenhagen University Hospital, Rigshospitalet | 40 | 2018-01-02 | 2018-01-10 |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma Fractionated proton radiation, Losartan - Vestibular Schwannoma, Acoustic Neuroma | Phase 2 | Active not recruiting | Massachusetts General Hospital | 30 | 2011-03-08 | 2026-09-11 |
Neuroma, Acoustic (4) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Meningioma (1) · Multiple Sclerosis (1) · Neoplasms (1) · Neurilemmoma (1) · Neurofibroma (1) · Neurofibromatosis 2 (1) · Neuroinflammatory Diseases (1)
Cranial Nerve Diseases (4) · Cranial Nerve Neoplasms (4) · Ear Diseases (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Nerve Sheath Neoplasms (4) · Nervous System Diseases (4) · Nervous System Neoplasms (4) · Neuroectodermal Tumors (4) · Neuroendocrine Tumors (4) · Neuroma (4) · Otorhinolaryngologic Diseases (4) · Otorhinolaryngologic Neoplasms (4)
Aspirin (1) · Losartan (1) · Mn-PyC3A (1)
Copenhagen University Hospital, Rigshospitalet (1) · Massachusetts Eye and Ear Infirmary (1) · Massachusetts General Hospital (1) · Reveal Pharmaceuticals Inc. (1)
United States (3) · Denmark (1)
D. Bradley Welling, MD, PhD (1) · Helen A. Shih, MD (1) · Hjalte C.R. Sass, MD, Ph.d.-Fellow (1) · Konstantina Stankovic, MD, PhD (1)
2017 (1), R44CA261240 (1)